FX volatility reaches highest since COVID-19 pandemic amid Middle East tensions
The daily volatility of the Korean won against the U.S. dollar has risen to its highest level since the COVID-19 pandemic amid heightened tensions in
Home
Page 214
New strikes light up the night in Tehran as Israel vows ‘many surprises’
DUBAI, United Arab Emirates — The Iran war exploded further late Saturday as pillars of flame rose above an oil storage facility in Tehran, and
Techysquad Highlights Shift Toward Long-Term SEO to Combat Rising Customer Acquisition Costs
Dubai, UAE, 7th March 2026, As digital advertising costs continue to rise globally, small and mid-sized enterprises (SMEs) are increasingly reassessing how they allocate their
Inside the booming business of wellness third spaces and membership clubs
A growing number of consumers are seeking out third spaces and membership clubs surrounding wellness, to improve their health while also socializing.
Usethebitcoin (UTB) Strengthens Position as a Leading Guide for Sending Crypto Remittances Globally
As global demand for faster and more affordable cross-border payments accelerates, Usethebitcoin (UTB) is reinforcing its position as a trusted resource for individuals and businesses
Iran’s president apologizes for strikes on neighbors as missiles and drones still pound their cities
DUBAI, United Arab Emirates — Iran’s president apologized Saturday for attacks on regional countries even as its missiles and drones flew toward Gulf Arab states,
BLACKPINK’s ‘Deadline’ lands at No. 11 on British Official Albums Chart
K-pop girl group BLACKPINK has entered the top 100 of Britain’s Official Albums Chart with its third EP “Deadline.” The record, which marks the quartet’s
[TEST DRIVE] Renault Korea’s Filante set to take on Santa Fe, Sorento
GYEONGJU, North Gyeongsang Province — Renault Korea’s new crossover Filante places comfort and refinement at the center of its identity, delivering the quiet and smooth
FDA vaccine head will step down in April after string of controversial decisions
Vinay Prasad is leaving his post as director of the Center for Biologics Evaluation and Research.
FDA reversals leave investors worrying about the fates of other experimental drugs
Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.